NEW DELHI: India’s central drug regulator, Central Drugs Standard Control Organisation (CDSCO), has clarified that pharmaceutical companies can re-label old stocks of their medicines with the revised Maximum Retail Prices (MRP) applicable following implementation of the Goods and Service Tax (GST) regime.
“… subject to provisions of Legal Metrology Act & Rules and other provisions of Act and Rules relating to Goods and Service Tax, this office has no objection for alteration of label (stickering) by the manufacturers under rule 104A of the Drugs and Cosmetics Rules, 1945, if required for implementation of GST,” stated the Central Drugs Standard Control Organisation in a notification on Monday evening.
The Ministry of Consumer Affairs, Food and Public Distribution last week stated in a circular that manufacturers, packers and importers of pre-packaged commodities should declare the post GST MRPs of unsold stocks which were manufactured, imported or packed before July 1.
So far, chemists had been selling old stocks of medicines at their pre-GST MRPs and pharma companies were expected to declare the new MRPs on the batches they manufactured after July 1.
